Table 2.
Variables | Before ARNI | After ARNI | Difference | P-value |
---|---|---|---|---|
Abnormal distribution* | ||||
PUF, ml/24 h | 389.1 (255.4, 536.6) | 485.7 (318.6, 647.5) | 66.4 (21.4, 123.2) | 0.004 |
Total output, ml/24 h | 836.3 (739.3, 919.3) | 905.7 (807.9, 1,002.9) | 81.1 (28.6, 139.3) | 0.003 |
UV, ml/24 h | 532.1 (418.6, 657.1) | 520.0 (378.6, 670.7) | 20.0 (−41.4, 61.4) | 0.446 |
Normal distribution ‡ | ||||
Body weight, kg | 60.0 (56.3, 63.8) | 59.6 (56.0, 63.2) | −0.4 (−0.7, −0.1) | 0.005 |
SBP, mmHg | 144.6 (139.0, 150.1) | 138.7 (133.5, 143.5) | −5.9 (−8.8, −3.0) | <0.001 |
DBP, mmHg | 91.9 (88.4, 95.5) | 89.5 (85.9, 93.0) | −2.4 (−4.6, −0.3) | 0.030 |
Abnormal distribution, using Wilcoxon paired signed rank test, a non-parametric 95%CI and an estimator for the pseudo-median of the difference of the location parameters is computed. The calculation of the p-value was based on the range of pseudo-median of the distribution of difference. Accordingly, the data before and after ARNI were expressed as pseudo-median (95% CI).
Normal distribution, Using paired sample t-test, a 95%CI and an estimator for the mean of the difference is computed. The calculation of the p-value was based on the range of the mean of difference. Accordingly, the data before and after ARNI were expressed as mean (95% CI).
PUF, peritoneal ultrafiltration; UV, urine volume; BP, blood pressure; PD, peritoneal dialysis; ARNI, angiotensin receptor-neprilysin inhibitor; SBP, systolic blood pressure; DBP, diastolic blood pressure; CI, confidence interval.